Fresenius Medical Care AG & Co. KGaA
NYSE:FMS · New York Stock Exchange
-$0.18 today
Vol 0.37M · Avg 0.72M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Stock Ticker Earnings Waterfall
NYSE:FMS · Revenue to Net Income
Key Ratios
Analysis
$19.4B of revenue converted into $944.7M of net income for the selected period. Gross margin is 25.9% and net margin is 4.8%, showing how much revenue survives after costs and taxes. EPS is $1.65, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $19.6B +1.5% | $19.3B -0.6% | $19.5B +0.3% | $19.4B +10.1% | $17.6B | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $14.6B +0.1% | $14.6B +0.3% | $14.5B +0.2% | $14.5B +12.9% | $12.8B | $725.6M | $804.0M | $882.4M |
| Gross Profit | $5.0B +5.7% | $4.8B -3.4% | $4.9B +0.6% | $4.9B +2.5% | $4.8B | $8.9B | $7.6B | $6.2B |
| Gross Margin | 25.6% +1.0pp | 24.6% -0.7pp | 25.3% +0.1pp | 25.2% -1.9pp | 27.1% | 9.8% | 28.9% | 38.3% |
| Research & Development | $158.0M -13.9% | $183.5M -20.9% | $232.0M +1.5% | $228.6M +3.6% | $220.8M | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $3.0B -3.5% | $3.1B -1.7% | $3.2B +0.8% | $3.2B +14.3% | $2.8B | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $3.2B -2.7% | $3.3B -7.5% | $3.6B +5.1% | $3.4B +15.8% | $2.9B | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $1.5B -13.9% | $1.7B -0.6% | $1.8B -4.7% | $1.8B +13.2% | $1.6B | $374.2M | $1.2B | $631.8M |
| EBITDA | $3.4B +6.0% | $3.2B -0.1% | $3.2B -6.1% | $3.4B -3.7% | $3.5B | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 17.3% +0.7pp | 16.6% +0.1pp | 16.5% -1.1pp | 17.6% -2.5pp | 20.1% | 5.6% | 46.3% | 42.0% |
| Operating Income | $1.8B +24.5% | $1.5B +7.2% | $1.4B -9.4% | $1.5B -18.4% | $1.9B | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 9.3% +1.7pp | 7.6% +0.5pp | 7.0% -0.8pp | 7.8% -2.7pp | 10.5% | 16.6% | 24.1% | 22.0% |
| Interest Income | $69.6M -2.7% | $71.6M -18.9% | $88.2M +30.4% | $67.7M -7.5% | $73.2M | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $384.4M -5.6% | $407.0M -4.1% | $424.6M +17.9% | $360.1M +1.8% | $353.6M | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$314.6M +23.4% | -$410.5M -22.0% | -$336.4M -15.0% | -$292.5M -4.3% | -$280.4M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | $1.5B +43.1% | $1.1B +2.3% | $1.0B -15.3% | $1.2B -22.4% | $1.6B | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | 7.7% +2.2pp | 5.5% +0.2pp | 5.3% -1.0pp | 6.3% -2.6pp | 8.9% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $321.0M +1.6% | $316.1M +5.2% | $300.6M -7.5% | $325.0M -7.9% | $352.8M | $1.3B | -$1.6B | $745.2M |
| Net Income | $978.4M +81.9% | $537.9M +7.8% | $499.0M -25.9% | $673.4M -30.5% | $969.3M | $4.9B | $4.8B | $4.7B |
| Net Margin | 5.0% +2.2pp | 2.8% +0.2pp | 2.6% -0.9pp | 3.5% -2.0pp | 5.5% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | $2 +82.6% | $1 +8.2% | $1 +49.1% | $1 -31.3% | $1 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | $2 +82.6% | $1 +8.2% | $1 +49.1% | $1 -31.3% | $1 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $582.4M -0.9% | $587.9M +0.1% | $587.1M -50.0% | $1.2B +0.1% | $1.2B | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $582.4M -0.8% | $586.8M +0.0% | $586.8M -50.0% | $1.2B +0.1% | $1.2B | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Royalty Pharma plc
NASDAQ:RPRX
$23.10B
Hologic, Inc.
HOLX
$16.97B
Tenet Healthcare Corporation
NYSE:THC
$15.38B
DaVita Inc.
NYSE:DVA
$13.52B
Solventum Corporation
NYSE:SOLV
$12.91B
Smith & Nephew plc
NYSE:SNN
$12.74B
ICON Public Limited Company
NASDAQ:ICLR
$10.97B
Encompass Health Corporation
NYSE:EHC
$9.71B
Universal Health Services, Inc.
NYSE:UHS
$8.84B
Tempus AI, Inc.
NASDAQ:TEM
$8.51B
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does FMS generate?
Fresenius Medical Care AG & Co. KGaA (FMS) reported $19.63B of revenue in fiscal 2025.
Is FMS profitable?
Fresenius Medical Care AG & Co. KGaA (FMS) reported $978.37M of net income, with a net margin of 5.0%.
Explore More
Continue the stock analysis
Jump to another research area for this company.